224 related articles for article (PubMed ID: 25476839)
1. Dosimetric predictors of hypothyroidism in oropharyngeal cancer patients treated with intensity-modulated radiation therapy.
Chyan A; Chen J; Shugard E; Lambert L; Quivey JM; Yom SS
Radiat Oncol; 2014 Dec; 9():269. PubMed ID: 25476839
[TBL] [Abstract][Full Text] [Related]
2. Thyroid V50 Highly Predictive of Hypothyroidism in Head-and-Neck Cancer Patients Treated With Intensity-modulated Radiotherapy (IMRT).
Sachdev S; Refaat T; Bacchus ID; Sathiaseelan V; Mittal BB
Am J Clin Oncol; 2017 Aug; 40(4):413-417. PubMed ID: 25503434
[TBL] [Abstract][Full Text] [Related]
3. Dosimetric Predictors of Hypothyroidism After Radical Intensity-modulated Radiation Therapy for Non-metastatic Nasopharyngeal Carcinoma.
Lee V; Chan SY; Choi CW; Kwong D; Lam KO; Tong CC; Sze CK; Ng S; Leung TW; Lee A
Clin Oncol (R Coll Radiol); 2016 Aug; 28(8):e52-60. PubMed ID: 27235379
[TBL] [Abstract][Full Text] [Related]
4. Validation of previously reported predictors for radiation-induced hypothyroidism in nasopharyngeal cancer patients treated with intensity-modulated radiation therapy, a post hoc analysis from a Phase III randomized trial.
Lertbutsayanukul C; Kitpanit S; Prayongrat A; Kannarunimit D; Netsawang B; Chakkabat C
J Radiat Res; 2018 Jul; 59(4):446-455. PubMed ID: 29750261
[TBL] [Abstract][Full Text] [Related]
5. Hypothyroidism as a consequence of intensity-modulated radiotherapy with concurrent taxane-based chemotherapy for locally advanced head-and-neck cancer.
Diaz R; Jaboin JJ; Morales-Paliza M; Koehler E; Phillips JG; Stinson S; Gilbert J; Chung CH; Murphy BA; Yarbrough WG; Murphy PB; Shyr Y; Cmelak AJ
Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):468-76. PubMed ID: 19577867
[TBL] [Abstract][Full Text] [Related]
6. Predictors of Hypothyroidism in Hodgkin Lymphoma Survivors After Intensity Modulated Versus 3-Dimensional Radiation Therapy.
Pinnix CC; Cella L; Andraos TY; Ayoub Z; Milgrom SA; Gunther J; Thosani S; Wogan C; Conson M; D'Avino V; Oki Y; Fanale M; Lee HJ; Neelapu S; Fayad L; Hagemeister F; Rodriguez MA; Nastoupil LJ; Nieto Y; Qiao W; Pacelli R; Dabaja B
Int J Radiat Oncol Biol Phys; 2018 Jul; 101(3):530-540. PubMed ID: 29681481
[TBL] [Abstract][Full Text] [Related]
7. Predictors of radiation-induced hypothyroidism in nasopharyngeal carcinoma survivors after intensity-modulated radiotherapy.
Zhai R; Lyu Y; Ni M; Kong F; Du C; Hu C; Ying H
Radiat Oncol; 2022 Mar; 17(1):57. PubMed ID: 35313921
[TBL] [Abstract][Full Text] [Related]
8. Dose-volume predictors of post-radiation primary hypothyroidism in head and neck cancer: A systematic review.
Chow JCH; Cheung KM; Cheung GTC; Tam AHP; Lui JCF; Lee FKH; Au KH; Ng WT; Lee AWM; Yiu HHY
Clin Transl Radiat Oncol; 2022 Mar; 33():83-92. PubMed ID: 35128087
[TBL] [Abstract][Full Text] [Related]
9. Hypothyroidism when the thyroid is included only in the low neck field during head and neck radiotherapy.
Norris AA; Amdur RJ; Morris CG; Mendenhall WM
Am J Clin Oncol; 2006 Oct; 29(5):442-5. PubMed ID: 17023776
[TBL] [Abstract][Full Text] [Related]
10. Clinical toxicities and dosimetric parameters after whole-pelvis versus prostate-only intensity-modulated radiation therapy for prostate cancer.
Deville C; Both S; Hwang WT; Tochner Z; Vapiwala N
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):763-72. PubMed ID: 20171807
[TBL] [Abstract][Full Text] [Related]
11. Brachial plexus dose tolerance in head and neck cancer patients treated with sequential intensity modulated radiation therapy.
Thomas TO; Refaat T; Choi M; Bacchus I; Sachdev S; Rademaker AW; Sathiaseelan V; Karagianis A; Mittal BB
Radiat Oncol; 2015 Apr; 10():94. PubMed ID: 25927572
[TBL] [Abstract][Full Text] [Related]
12. Radiation-induced hypothyroidism after IMRT for nasopharyngeal carcinoma: Clinical and dosimetric predictors in a prospective cohort study.
Zhai RP; Kong FF; Du CR; Hu CS; Ying HM
Oral Oncol; 2017 May; 68():44-49. PubMed ID: 28438291
[TBL] [Abstract][Full Text] [Related]
13. Thyroid V30 predicts radiation-induced hypothyroidism in patients treated with sequential chemo-radiotherapy for Hodgkin's lymphoma.
Cella L; Conson M; Caterino M; De Rosa N; Liuzzi R; Picardi M; Grimaldi F; Solla R; Farella A; Salvatore M; Pacelli R
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1802-8. PubMed ID: 21514076
[TBL] [Abstract][Full Text] [Related]
14. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.
Chau RM; Teo PM; Kam MK; Leung SF; Cheung KY; Chan AT
Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826
[TBL] [Abstract][Full Text] [Related]
15. Normal tissue complication probability modeling of acute hematologic toxicity in patients treated with intensity-modulated radiation therapy for squamous cell carcinoma of the anal canal.
Bazan JG; Luxton G; Mok EC; Koong AC; Chang DT
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):700-6. PubMed ID: 22414279
[TBL] [Abstract][Full Text] [Related]
16. Thyroid dose-volume thresholds for the risk of radiation-related hypothyroidism in nasopharyngeal carcinoma treated with intensity-modulated radiotherapy-A single-institution study.
Huang CL; Tan HW; Guo R; Zhang Y; Peng H; Peng L; Lin AH; Mao YP; Sun Y; Ma J; Tang LL
Cancer Med; 2019 Nov; 8(16):6887-6893. PubMed ID: 31560840
[TBL] [Abstract][Full Text] [Related]
17. Thyroid V
Zhou L; Chen J; Shen W; Chen ZL; Huang S; Tao CJ; Chen M; Yu ZH; Chen YY
Radiat Oncol; 2020 Mar; 15(1):68. PubMed ID: 32293496
[TBL] [Abstract][Full Text] [Related]
18. Post-radiation primary hypothyroidism in patients with head and neck cancer: External validation of thyroid gland dose-volume constraints with long-term endocrine outcomes.
Chow JCH; Lui JCF; Cheung KM; Tam AHP; Lam MHC; Yuen TYS; Lee FKH; Leung AKC; Au KH; Ng WT; Lee AWM; Kwan CK; Yiu HHY
Radiother Oncol; 2022 Dec; 177():105-110. PubMed ID: 36336109
[TBL] [Abstract][Full Text] [Related]
19. Hypothyroidism after 3-dimensional conformal radiotherapy and intensity-modulated radiotherapy for head and neck cancers: prospective data from 2 randomized controlled trials.
Murthy V; Narang K; Ghosh-Laskar S; Gupta T; Budrukkar A; Agrawal JP
Head Neck; 2014 Nov; 36(11):1573-80. PubMed ID: 23996654
[TBL] [Abstract][Full Text] [Related]
20. Factors predictive of the development of hypothyroidism after intensity-modulated radiation therapy for pharyngeal cancer.
Inoue E; Okajima K; Doi H; Fukuda K; Oguma Y; Ri A; Nishikawa D; Yane K; Matsuura T; Nishimura Y
Acta Otolaryngol; 2021 Nov; 141(11):1022-1026. PubMed ID: 34738883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
